Butterfly Network BFLY
NYSE BFLY
$9.16 -0.01 (-0.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026)

Butterfly Network (BFLY) posted Liabilities and Shareholders Equity of $283.0 million for Q2 2026, down 1.02% sequentially from $285.9 million in Q1 2026, and down 9.67% YoY from $313.3 million in Q2 2025.

Butterfly Network (BFLY) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Butterfly Network has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $283.0 million in Q2 2026.

  • Quarterly Liabilities and Shareholders Equity fell 9.67% year-over-year to $283.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (changed 0.21% YoY) and the FY2025 annual result came in at $296.5 million, up 15.8% from the prior year.
  • Liabilities and Shareholders Equity declined to $283.0 million in Q2 2026 per BFLY's latest filing, from $285.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $535.4 million in Q1 2022 and troughed at $256.1 million in Q4 2024.
  • A 5-year average of $341.3 million and a median of $308.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity fell 28.71% in 2023, then advanced 15.8% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $417.6 million in 2022, then dropped by 27.13% to $304.3 million in 2023, then fell by 15.84% to $256.1 million in 2024, then grew by 15.8% to $296.5 million in 2025, then dropped by 4.57% to $283.0 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $283.0 million, $285.9 million, and $296.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Butterfly Network 2.41 Bn 2.28 Bn 23.29 Mn 283.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 283.00 Mn
Mar 31, 2026 285.92 Mn
Dec 31, 2025 296.53 Mn
Sep 30, 2025 290.00 Mn
Jun 30, 2025 313.28 Mn
Mar 31, 2025 318.41 Mn
Dec 31, 2024 256.08 Mn
Sep 30, 2024 265.27 Mn
Jun 30, 2024 273.07 Mn
Mar 31, 2024 284.29 Mn
Dec 31, 2023 304.27 Mn
Sep 30, 2023 334.22 Mn
Jun 30, 2023 364.59 Mn
Mar 31, 2023 381.68 Mn
Dec 31, 2022 417.57 Mn
Sep 30, 2022 443.26 Mn
Jun 30, 2022 496.64 Mn
Mar 31, 2022 535.42 Mn
Dec 31, 2021 571.97 Mn
Sep 30, 2021 580.32 Mn